Chemotherapy, radiation, targeted therapy, and immunotherapy have given cancer patients hope. As cancer patient survival rates have increased and clinical experience has grown, interest in cardiovascular damage caused by cancer therapy has grown. To develop appropriate preventative and therapeutic strategies for the side effects of cancer treatment that can be fatal or cause long-term morbidity, a greater comprehension of the disease's molecular biology is required. In addition to common cardio protection medications, formulations of traditional Chinese medicine can be expected to achieve "tailored treatment" from a variety of angles. In addition, the emergence of "reverse cardiooncology" in response to the rising incidence of cancer among cardiovascular disease patients emphasizes the urgent requirement for collaboration between cardiologists and oncologists.
HTML PDFShare this article
Cancer Science & Therapy received 3968 citations as per Google Scholar report
